Detalhe da pesquisa
1.
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
BMC Med
; 22(1): 9, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191387
2.
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.
Br J Cancer
; 126(10): 1401-1409, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124703
3.
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600mutated melanoma.
Clin Cancer Res
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739109
4.
High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nat Med
; 29(3): 588-592, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732628
5.
Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.
Nat Med
; 30(1): 304, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37460757